Skip to main content

Scott Burchiel, PhD

Senior Associate Dean: Pharmaceutical Sciences

Distinguished Emeritus Professor and DeSantis Chair of Pharmacogenomics

Photo: true

Contact Information

Office Location: NRPH Rm B29
Phone: (505) 272-0920

Academic Career

Burchiel received a BS in biochemistry from the University of California, Davis, in 1973 and a PhD in pharmacology from the University of California, San Francisco, in 1977. He was a postdoctoral fellow at UNM School of Medicine’s Immunology Laboratory before joining the College of Pharmacy.

Research Interests

Burchiel is an expert in immunotoxicology and environmental carcinogenesis. He has written more than 125 scientific manuscripts and has been continually funded by the NIH for more than 25 years. He is an active NIH reviewer and is an Editor in Chief of Toxicology and Applied Pharmacology. His research focuses on the effects of environmental agents on the immune system of humans and animal models, gene-environment interactions and epigenetics of immune suppression. Burchiel’s laboratory is known for its use of flow cytometry to study immune cell phenotyping and function, as well as signaling and cell injury pathways. Current studies focus on environmental public health issues in populations exposed to arsenic.

Professional Memberships

  • American Association for Cancer Research (1995-date)
  • American Association of Colleges of Pharmacy (1980-2000)
  • American Association of Immunologists (1985-date)
  • Society of Toxicology (1985-date)
  • Academy of Toxicologic Sciences (2009-date)


Burchiel Named First Chair of Pharmacogenomics
(HSCNewsBeat; March 29, 2007) ─ Dr. Scott ALBUQUERQUE, N.M. - Dr. Scott W. Burchiel has been named the first chair holder of the Nunzio and Sherolyn De Santis Endowed Chair in Pharmacogenomics at the University of New Mexico College of Pharmacy.

New Mexico center for Isotopes in Medicine
(HSCNewsBeat; October 2, 2006) ─The Director of the NMCIM and Principal Investigator of the TRC award, Dr. Scott Burchiel, is a pharmacologist with experience in the development of antibody-based imaging agents that have been developed by pharmaceutical and biotech companies over the past 20 years.